drugset / Trial / NCT05786950

Neural Respiratory Drive of Patients With Chronic Obstructive Pulmonary Disease

NCT05786950

NaSingle-groupOpen-labelBasic science

Summary

To investigate the relationship among the neural respiratory drive (NRD), the sensation of the dyspnea and the effect of the bronchodilator on each stage COPD patients.

Timeline

Start
2023-01-01
Primary completion
2023-07-01
Completion
2024-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ipratropium Small molecule 500 ug Inhaled
Subject Salbutamol Unknown 3 mg Inhaled